Presentation 学会発表

Establishment of SARS-CoV-2 Spike-mediated membrane fusion assay to evaluate fusogenicity of the novel emerging variants. SRC2024. 熊本, 2024年7月19-20日. Talk.

Nasser H, Suzuki R, Shimizu R, The Genotype to Phenotype Japan (G2P-Japan) Consortium, Saito A, Sato K, Matsuno K, Fukuhara T, Ikeda T. Establishment of SARS-CoV-2 Spike-mediated membrane fusion assay to evaluate fusogenicity of the novel emerging variants. SRC2024. 熊本, 2024年7月19-20日. Talk.